Results 141 to 150 of about 3,343,278 (165)

Unveiling differential gene co-expression networks and its effects on levodopa-induced dyskinesia. [PDF]

iScience
Piedade de Souza T, Santana de Araújo G, Magalhães L, Cavalcante GC, Ribeiro-Dos-Santos A, Sena-Dos-Santos C, Silva CS, Eufraseo GL, de Freitas Escudeiro A, Soares-Souza GB, Santos-Lobato BL, Ribeiro-Dos-Santos Â.   +11 more
europepmc   +1 more source

Translational profiling reveals novel gene expression changes in the direct and indirect pathways in a mouse model of levodopa induced dyskinesia. [PDF]

Front Cell Neurosci
Jafri S, Ghani M, Stickle N, Virtanen C, Hazrati LN, Visanji NP.   +5 more
europepmc   +1 more source

The Early Onset of Levodopa-induced Dyskinesia in a Patient with Multiple System Atrophy. [PDF]

Intern Med
Okusa S, Nakahara J, Seki M.
europepmc   +1 more source

Altered perivascular spaces in subcortical white matter in Parkinson's disease patients with levodopa-induced dyskinesia. [PDF]

NPJ Parkinsons Dis
Cao X, Gan C, Zhang H, Yuan Y, Sun H, Zhang L, Wang L, Zhang L, Zhang K.   +8 more
europepmc   +1 more source

Bidirectional regulation of levodopa-induced dyskinesia by a specific neural ensemble in globus pallidus external segment. [PDF]

Cell Rep Med
Shen C, Shen B, Liu D, Han L, Zou K, Gan L, Ren J, Wu B, Tang Y, Zhao J, Sun Y, Liu F, Yu W, Yao H, Wu J, Wang J.   +15 more
europepmc   +1 more source

Microstructural and functional alterations of the ventral pallidum are associated with levodopa-induced dyskinesia in Parkinson's disease. [PDF]

Eur J Neurol
Gan Y, Su D, Zhang Z, Zhang Z, Yan R, Liu Z, Wang Z, Zhou J, Lam JST, Wu T, Jing J, Feng T.   +11 more
europepmc   +1 more source

Continuous long-range measurement of tonic dopamine with advanced FSCV for pharmacodynamic analysis of levodopa-induced dyskinesia in Parkinson's disease. [PDF]

Front Bioeng Biotechnol
Park J, Kang S, Lee Y, Choi JW, Oh YS.
europepmc   +1 more source

Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease

Parkinsonism and Related Disorders, 2014
BACKGROUND: The antiepileptic drug topiramate reduces levodopa-induced dyskinesia without exacerbating parkinsonism in animal models. We report a randomized, double-blind, placebo-controlled crossover trial in patients with Parkinson's disease and ...
David Burn, Lewis Kass-Iliyya, Monty Silverdale   +2 more
exaly   +2 more sources

Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Brain, 2000
We investigated the role of dopamine neurons in the manifestation of levodopa-induced dyskinesia in a rat model of Parkinson's disease. Daily treatment with a subthreshold dose of levodopa gradually induced abnormal involuntary movements (AIM) in 6 ...
Anders Björklund, M Angela Cenci Nilsson, Michael Schulzer   +2 more
exaly   +1 more source

Some of the next articles are maybe not open access.

Related searches:

White matter connectivity networks predict levodopa-induced dyskinesia in Parkinson’s disease

Journal of Neurology, 2021
Seok Jong Chung, Hye Sun Lee, Young H. Sohn   +2 more
exaly